Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


M3 Biotechnology, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/28/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/22/2020 4 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 1,644,785 shares @ $0
Bought 1,058,824 shares @ $17, valued at $18M
Converted 1,644,785 preferred shares @ $0
09/22/2020 4 EDELMAN JOSEPH (10% Owner) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 1,644,785 shares @ $0
Bought 1,058,824 shares @ $17, valued at $18M
Converted 1,644,785 preferred shares @ $0
09/22/2020 4 FLUKE JOHN M JR (Director) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 12,610 shares @ $0
Converted 51,831 shares @ $0
Converted 6,731 shares @ $0
Converted 12,610 preferred shares @ $0
Converted 51,831 preferred shares @ $0
Converted 6,731 preferred shares @ $0
09/22/2020 4 Litton Mark James (COO) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 13,126 shares @ $0
Converted 6,563 shares @ $0
Converted 13,126 preferred shares @ $0
Converted 6,563 preferred shares @ $0
09/22/2020 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on Athira Pharma, Inc.
Txns: Converted 1,535,131 shares @ $0
Bought 750,000 shares @ $17, valued at $12.8M
Converted 1,535,131 convertible preferred @ $0
09/18/2020 3 FLUKE JOHN M JR (Director) has filed a Form 3 on Athira Pharma, Inc.
09/18/2020 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
09/18/2020 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
09/18/2020 EFFECT Form EFFECT - Notice of Effectiveness:
09/17/2020 3 PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 JOHNSON JAMES A (Director) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 EDELMAN JOSEPH (10% Owner) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 Yamada Tadataka (Director) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 Litton Mark James (COO) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 CHURCH KEVIN (Vice President of Discovery) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 MOEBIUS HANS (Chief Medical Officer) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 MILESON GLENNA (CFO) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 KAWAS LEEN (President & CEO) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 3 RTW INVESTMENTS, LP (10% Owner) has filed a Form 3 on Athira Pharma, Inc.
09/17/2020 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
09/17/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
09/16/2020 CERT Form CERT -
09/14/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
09/09/2020 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
08/26/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
06/12/2020 D Form D - Notice of Exempt Offering of Securities:
09/18/2019 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
11/01/2017 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy